Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
Episode 18 with Dr. Samuel Ludwin on new approaches to remyelination therapies.
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis.
Origin, fate and dynamics of macrophages at central nervous system interfaces.
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone).
Demyelination and Remyelination: From Mechanism to Therapy
Assessment and Imaging of the Cerebrovascular Glycocalyx.
Episode 35 with Dr. Daniel Reich on neuroradiology in MS
The quality of reports of randomized trials in multiple sclerosis: a review.
US and EU regulatory authorities accept oral BG-12 marketing applications for review
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Mitoxantrone - an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis.
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
ForuMS: A Virtual Journal Club for MS Clinicians
SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
Masitinib mesylate application for conditional approval
Meta-analysis of adverse events in recent randomized clinical trials for dimethil fumarate, glatiramer acetate and teriflunomide for the treatment of relapsing forms of multiple sclerosis.
Cost Effectiveness of Fingolimod, Teriflunomide, Dimethyl Fumarate and Intramuscular Interferon-β1a in Relapsing-Remitting Multiple Sclerosis.
Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies.
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination.

Pages